# US 2002/0055133 A1 · Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0055133 A1
- Document ID: US20020055133A1
- Status: Published application
- Kind: A1
- Application number: 09/839,577
- Filed: 2001-04-20
- Published: 2002-05-09
- Earliest claimed: 2000-07-13
- Assignees: The Scripps Research Institute
- Inventors: Klaus M. Hahn; Alexei Toutchkine; Rajeev Muthyala; Vadim Kraynov; Steven J. Bark; Dennis R. Burton; Chester Chamberlain
- Web page: https://patentgrep.com/patent/US20020055133A1

## CPC

- C07K 1/1077: {by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids}
- C07K 1/13: Labelling of peptides
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The invention provides peptide synthons having protected functional groups for attachment of desired moieties (e.g. functional molecules or probes). Also provided are peptide conjugates prepared from such synthons, and synthon and conjugate preparation methods including procedures for identifying the optimum probe attachment site. Biosensors are provided having environmentally sensitive dyes that can locate specific biomolecules within living cells and detect chemical and physiological changes in those biomolecules as the living cell is moving, metabolizing and reacting to its environment. Methods are included for detecting GTP activation of a Rho GTPase protein using polypeptide biosensors. When the biosensor binds GTP-activated Rho GTPase protein, the environmentally sensitive dye emits a signal of a different lifetime, intensity or wavelength than when not bound. New fluorophores whose fluorescence responds to environmental changes are also provided that have improved detection and attachment properties, and that can be used in living cells, or in vitro.

## Claims

### Claim 1

A compound of formula (I):
14
wherein
R1 is hydrogen or an amino protecting group;
R2 is hydrogen or a carboxy protecting group;
R is an organic radical comprising one or more aminooxy groups.

### Claim 2 (depends on 1)

The compound of claim 1 wherein R is a radical of formula (V):
15
wherein
R3 is hydrogen, (C1-C6) alkyl, an amino protecting group, or a radical comprising one or more aminooxy groups;
R4 is hydrogen, or an amino protecting group; and
R5 is hydrogen, or (C1-C6)alkyl.

### Claim 3 (depends on 2)

The compound of claim 2 which is a compound of formula (II):
16
wherein:
R1 is hydrogen or an amino protecting group;
R2 is hydrogen or a carboxy protecting group;
R3 is (C1-C6)alkyl;
R4 is hydrogen, or an amino protecting group; and
R5 is hydrogen.

### Claim 4 (depends on 3)

The compound of claim 3 wherein R4 is 2-chlorobenzyloxycarbonyl.

### Claim 5 (depends on 1)

The compound of claim 1 which is α-benzyloxycarbonyl-β-[N-(2-chlorobenzyloxycarbonyl)-N-methylaminooxyacetyl]-α,β-diaminopropionic acid.

### Claim 6

A peptide comprising a backbone and one or more aminooxy groups;
provided the peptide is not glutathione; and
provided the peptide has at least one aminooxy group that is not part of a group H2N—O—CH2—C(═O)— positioned at the N-terminus of the peptide or that is not part of a group —C═N—O—CH2—C(═O)— that is in the backbone.

### Claim 7

A peptide comprising a backbone and one or more secondary aminooxy groups;
provided the peptide has at least one aminooxy group that is not part of an oxime (C═N—O—) in the backbone.

### Claim 8

A peptide conjugate of formula (III):
17
wherein
R6 is a peptide or polypeptide;
X is a direct bond or a linking group;
R7 is hydrogen, (C1-C6)alkyl, an amino protecting group, or a radical comprising one or more aminooxy groups;
Y is a direct bond or a linking group; and
D is a functional molecule.

### Claim 9 (depends on 8)

The peptide conjugate of claim 8 wherein R6 is an antibody.

### Claim 10 (depends on 8)

The peptide conjugate of claim 8 wherein R6 comprises about 2 to about 1000 amino acids.

### Claim 11 (depends on 8)

The peptide conjugate of claim 8 wherein R6 comprises about 5 to about 500 amino acids.

### Claim 12 (depends on 8)

The peptide conjugate of claim 8 wherein R6 comprises about 10 to about 100 amino acids.

### Claim 13 (depends on 8)

The peptide conjugate of claim 8 wherein X is about 5 angstroms to about 100 angstroms in length.

### Claim 14 (depends on 8)

The peptide conjugate of claim 8 wherein X is about 5 angstroms to about 25 angstroms in length.

### Claim 15 (depends on 8)

The peptide conjugate of claim 8 wherein X is —Ra—C(═O)—NH—Rb— wherein each of Ra and Rb is independently (C1-C6)alkylene.

### Claim 16 (depends on 15)

The peptide conjugate of claim 15 wherein each of Ra and Rb is methylene (—CH2—).

### Claim 17 (depends on 8)

The peptide conjugate of claim 8 wherein R7 is hydrogen.

### Claim 18 (depends on 8)

The peptide conjugate of claim 8 wherein R7 is (C1-C6)alkyl.

### Claim 19 (depends on 8)

The peptide conjugate of claim 8 wherein R7 is methyl.

### Claim 20 (depends on 8)

The peptide conjugate of claim 8 wherein R7 is a radical comprising one or more aminooxy groups.

### Claim 21 (depends on 8)

The peptide conjugate of claim 8 wherein Y is about 5 angstroms to about 100 angstroms in length.

### Claim 22 (depends on 8)

The peptide conjugate of claim 8 wherein Y is about 5 angstroms to about 25 angstroms in length.

### Claim 23 (depends on 8)

The peptide conjugate of claim 8 wherein Y is (C1-C6)alkylene.

### Claim 24 (depends on 8)

The peptide conjugate of claim 8 wherein Y is methylene (—CH2—).

### Claim 25 (depends on 8)

The peptide conjugate of claim 8 wherein D is a biophysical probe, a peptide, a polynucleotide, or a therapeutic agent.

### Claim 26 (depends on 8)

The peptide conjugate of claim 8 wherein D is a cross-linking group or a caged response modifier.

### Claim 27 (depends on 8)

The peptide conjugate of claim 8 wherein D is a biophysical probe.

### Claim 28 (depends on 27)

The peptide of claim 27 wherein the biophysical probe is a fluorescent group, a phosphorescent group, a nucleic acid indicator, an ESR probe, a responsive sensor, a caged sensor, or a dye that is sensitive to pH change, ligand binding, or other environmental aspects.

### Claim 29 (depends on 8)

The peptide of claim 8 wherein D is a peptide.

### Claim 30 (depends on 8)

The peptide of claim 8 wherein D is a polynucleotide.

### Claim 31 (depends on 30)

The peptide of claim 30 wherein the polynucleotide is DNA

### Claim 32 (depends on 30)

The peptide of claim 30 wherein the polynucleotide is RNA

### Claim 33 (depends on 8)

The peptide of claim 8 wherein D is a therapeutic agent.

### Claim 34 (depends on 8)

The peptide of claim 8 wherein D is an Alexa dye, a solvatochromic dye, an electrochromatic dye, or a dye that is sensitive to pH change, ligand binding, or other environmental aspects.

### Claim 35 (depends on 8)

The peptide of claim 8 wherein D is Alexa-532, Hydroxycoumarin, Aminocoumarin, Methoxycoumarin, Amino methylcoumarin, Cascade Blue, Lucifer Yellow, NBD, P-Phycoerythrin, R-Phycoerythrin, (PE), PE-Cy5 conjugates, PE-Cy7 conjugates, Red 613, Fluorescein, BODIPY-FL, BODIPY TR, BODIPY TMR, Cy3, TRITC, X-Rhodamine, Lissamine Rhodamine B, PerCP, Texas Red, Cy5, Cy7, Allophycocyanin (APC), TruRed, APC-Cy7 conjugates, Oregon Green, Tetramethylrhodamine, Dansyl, Indo-l, Fura-2, FM 1-43, DilC18(3), Carboxy-SNARF-l, NBD, Indo-l, Fluo-3, DCFH, DHR, SNARF, or Monochlorobimane, Calcein.

### Claim 36 (depends on 8)

The peptide of claim 8 wherein D is YOYO-1, Propidium Iodide, Hoechst 33342, DAPI, Hoerchst 33258, SYTOX Blue, Chromomycin A3, Mithramycin, SYTOX Green, SYTX Orange, Ethidium Bromide, 7-AAD, Acridine Orange, TOTO-1, TO-PRO-1, Thiazole Orange, Propidium Iodide, TOTO-3, TO-PRO-3, or LDS 751.

### Claim 37 (depends on 8)

The peptide of claim 8 wherein:
R6 is (SEQ ID NO. 1);
X is Ra—C(═O)CH(NH2)CH2N(H)C(═O)CH2—Rb; wherein Ra is a direct bond to the amino terminus of R6 and wherein Rb is a direct bond to the oxygen of the aminooxy group of formula (III);
R7 is methyl;
Y is a direct bond; and
D is Alexa-532.

### Claim 38

A method for preparing a peptide conjugate comprising a peptide linked to a functional molecule, comprising reacting a peptide having one or more secondary aminooxy groups with a corresponding functional molecule having an electrophilic moiety that is reactive with the aminooxy group(s), to provide the peptide conjugate.

### Claim 39

A method for preparing a peptide conjugate comprising a peptide linked to a functional molecule, comprising reacting a peptide having one or more aminooxy groups with a corresponding functional molecule having an electrophilic moiety that is reactive with the aminooxy group(s), to provide the peptide conjugate; provided that the functional molecule is not a peptide.

### Claim 40

A method for preparing a peptide conjugate comprising a peptide linked to a functional molecule, comprising reacting a peptide having one or more aminooxy groups with a corresponding functional molecule having an electrophilic moiety that is reactive with the aminooxy group(s), to provide the peptide conjugate; provided that the peptide and the functional molecule are not attached through an oxime (C═N—O—) linkage.

### Claim 41

A method for preparing a peptide conjugate comprising a functional molecule linked to a peptide having a backbone, comprising reacting a peptide having one or more aminooxy groups with a corresponding functional molecule having an electrophilic moiety that is reactive with the aminooxy group(s), to provide the peptide conjugate; provided that when the functional molecule is a second peptide, the functional molecule and the first peptide are not linked through a —C═N—O—CH2—C(═O)— linkage in the backbone of the first peptide.

### Claim 42

A peptide conjugate of formula (IV):
18
wherein
R6 is a peptide, polypeptide or antibody;
X is a direct bond or a linking group;
R7 is hydrogen, (C1-C6)alkyl, an amino protecting group, or a radical comprising one or more aminooxy groups;
Z is a linking group, or Z is a direct single bond or a double bond between N and D; and
D is a functional molecule;
provided that when D is a peptide, N and D are not linked through a —C═N—O—CH2—C(═O)— linkage in the backbone of the peptide conjugate.

### Claim 43 (depends on 42)

The peptide conjugate of claim 42 wherein R6is an antibody.

### Claim 44

A method of identifying an optimal position for placement of a functional molecule on a peptide having a peptide backbone and a known activity, which comprises making a series of peptide conjugates, each peptide conjugate having the same amino acid sequence and the same functional molecule, wherein the functional molecule is linked at a different location along the backbone of every peptide conjugate in the series, and observing which functional group location does not substantially interfere with the known activity of the peptide.

### Claim 45 (depends on 8, 42, 44)

The method of claim 44 wherein each peptide of said series of peptide conjugates comprises the peptide conjugate of claim 8 or 42.

### Claim 46

A method of identifying an optimal position for placement of a functional molecule in a polypeptide having a known activity and an identified peptide segment for attachment of the functional molecule, which comprises:
a) making a series of peptide conjugates, each peptide conjugate having the amino acid sequence of the identified peptide segment and the same functional molecule, wherein the functional molecule is linked at a different location along the backbone of every peptide conjugate in the series;
b) placing a peptide conjugate within, or at the end of, each polypeptide of a series of polypeptides to create a series of polypeptide conjugates each having the functional group at a different location; and
c) observing which functional group location does not substantially interfere with the known activity of the polypeptide.

### Claim 47 (depends on 8, 42, 46)

The method of claim 46 wherein each peptide of said series of peptides comprises the peptide conjugate of claim 8 or 42.

### Claim 48 (depends on 46)

The method of claim 46 wherein each peptide conjugate is placed within, or at the end of, each polypeptide by natural chemical ligation, intein-mediated protein ligation or chemical ligation.

### Claim 49

A method of identifying an optimal position for placement of an environmentally-sensitive functional molecule on a peptide biosensor having a backbone, which comprises making a series of peptide conjugates, each peptide conjugate having the same amino acid sequence and the same functional molecule, wherein the functional molecule is at a different location along the backbone of every peptide conjugate in the series, and observing which functional group location provides the strongest signal change in response to an environmental change in the peptide conjugate.

### Claim 50 (depends on 8, 42, 49)

The method of claim 49 wherein each peptide conjugate of said series of peptide conjugates comprises the peptide conjugate of claim 8 or 42.

### Claim 51 (depends on 49)

The method of claim 49 wherein each peptide conjugate is part of a polypeptide, antibody, antibody fragment, antibody fragment with linked chains or antibody with linked chains.

### Claim 52 (depends on 49)

The method of claim 49 wherein said signal change is a change in phosphorescence, fluorescence emission intensity, fluorescence lifetime, fluorescence excitation wavelength or fluorescence emission wavelength.

### Claim 53 (depends on 49)

The method of claim 49 wherein said environmental change in said peptide biosensor is interaction with a target.

### Claim 54 (depends on 53)

The method of claim 53 which further comprises observing the binding affinity of each peptide conjugate for target or the binding selectivity of each peptide conjugate for target.

### Claim 55

A method of identifying an optimal position for placement of an environmentally-sensitive functional molecule in a polypeptide having a known activity and an identified peptide segment for attachment of the functional molecule, which comprises:
a) making a series of peptide conjugates, each peptide conjugate having the amino acid sequence of the identified peptide segment and the same environmentally-sensitive functional molecule, wherein the environmentally-sensitive functional molecule is linked at a different location along the backbone of every peptide conjugate in the series;
b) placing a peptide conjugate within, or at the end of, each polypeptide of a series of polypeptides to create a series of polypeptide conjugates each having the environmentally-sensitive functional group at a different location; and
c) observing which functional group location provides the strongest signal change in response to an environmental change in the polypeptide conjugate.

### Claim 56 (depends on 8, 42, 55)

The method of claim 55 wherein each peptide conjugate of said series of peptide conjugates comprises the peptide conjugate of claim 8 or 42.

### Claim 57 (depends on 55)

The method of claim 55 wherein each peptide conjugate is placed within, or at the end of, each polypeptide by natural chemical ligation, intein-mediated protein ligation or chemical ligation.

### Claim 58 (depends on 55)

The method of claim 55 wherein said signal change is a change in phosphorescence, fluorescence emission intensity, fluorescence lifetime, fluorescence excitation wavelength or fluorescence emission wavelength.

### Claim 59 (depends on 55)

The method of claim 55 wherein said environmental change in said protein conjugate is interaction with a target or a change in activation state of a target.

### Claim 60 (depends on 59)

The method of claim 59 which further comprises observing the binding affinity of each peptide conjugate for target or the binding selectivity of each peptide conjugate for target.

### Claim 61 (depends on 8, 42)

A polypeptide biosensor which comprises the peptide conjugate of claim 8 or 42.

### Claim 62 (depends on 61)

The polypeptide biosensor of claim 61 which comprises a p21 activated kinase peptide capable of binding Rac or a Wiscott-Aldrich Syndrome Protein peptide capable of binding cdc42.

### Claim 63

A polypeptide biosensor comprising a polypeptide capable of binding a GTP-activated Rho GTPase protein, wherein said polypeptide is operatively linked to a fluorescent dye which is capable of fluorescence resonance energy transfer with a fluorescence dye on said GTP-activated Rho GTPase protein.

### Claim 64 (depends on 63)

The polypeptide biosensor of claim 63 wherein said Rho GTPase protein is Rac or cdc42.

### Claim 65 (depends on 63)

The polypeptide biosensor of claim 63 wherein said polypeptide comprises the protein binding domain of p21 activated kinase 1.

### Claim 66 (depends on 63)

The protein biosensor of claim 63 wherein said fluorescence dye on said GTP-activated Rho GTPase protein is Green Fluorescence Protein (GFP), Cyan Fluorescence Protein(CFP), Red Fluorescence Protein (RFP) or enhanced GFP (EGFP).

### Claim 67 (depends on 8, 42)

A fusion protein comprising a biologically active Rho GTPase protein domain operatively linked to a fluorescent protein via the peptide conjugate of claim 8 or 42, wherein said Rho GTPase protein domain is capable of binding GTP and forming an activated GTPase:GTP complex.

### Claim 68 (depends on 67)

The fusion protein of claim 67 wherein said Rho GTPase protein domain is derived from a Rac, Rho or cdc42 protein.

### Claim 69 (depends on 67)

The fusion protein of claim 67 wherein said fluorescence protein is green fluorescence protein, cyan fluorescence protein, red fluorescence protein, yellow fluorescence protein, enhanced green fluorescence protein or enhanced yellow fluorescence protein.

### Claim 70 (depends on 67)

A nucleic acid encoding the fusion protein of claim 67.

### Claim 71 (depends on 67)

An expression vector capable of expressing the fusion protein encoded by the nucleic acid of claim 67.

### Claim 72 (depends on 71)

A cell comprising the expression vector of claim 71.

### Claim 73

A method for detecting GTP activation of a Rho GTPase protein in a live cell comprising:
a) introducing a Rho GTPase protein to said cell, wherein said Rho GTPase protein is operatively linked to a fluorescence dye capable of undergoing fluorescence resonance energy transfer;
b) introducing a polypeptide biosensor into said cell, wherein said polypeptide biosensor comprises a polypeptide capable of binding a GTP-activated Rho GTPase protein, and wherein said polypeptide is operatively linked to a fluorescent dye which can undergo fluorescence resonance energy transfer with said fluorescence dye on said GTP-activated Rho GTPase protein when said polypeptide biosensor interacts with said GTP-activated Rho GTPase; and
c) observing fluorescence emissions from said polypeptide biosensor within said live cell.

### Claim 74 (depends on 73)

The method of claim 73 which further comprises observing fluorescence emissions from said fluorescence dye on said GTP-activated Rho GTPase.

### Claim 75 (depends on 8, 42, 73)

The method of claim 73 wherein said polypeptide biosensor comprises the peptide conjugate of claim 8 or 42.

### Claim 76

A method for detecting GTP activation of a Rho GTPase protein, which comprises:
a) contacting a polypeptide biosensor with a test substance, wherein said polypeptide biosensor comprises a polypeptide capable of binding a GTP-activated Rho GTPase protein, and wherein said polypeptide is operatively linked to an environmentally sensitive dye; and
b) observing a signal from said polypeptide;
wherein said environmentally sensitive dye will emit a signal of a different lifetime, intensity or wavelength when said polypeptide biosensor is bound to said GTP-activated Rho GTPase protein than when said polypeptide biosensor is not bound.

### Claim 77

A method for detecting GTP activation of a Rho GTPase protein in a live cell comprising:
a) introducing a polypeptide biosensor into said cell, wherein said polypeptide biosensor comprises a polypeptide capable of binding a GTP-activated Rho GTPase protein, and wherein said polypeptide is operatively linked to an environmentally sensitive dye; and
b) observing a signal from said environmentally sensitive dye within said live cell;
wherein said environmentally sensitive dye will emit a signal of a different lifetime, intensity or wavelength when said polypeptide biosensor is bound to said GTP-activated Rho GTPase protein than when said polypeptide biosensor is not bound.

### Claim 78 (depends on 8, 42, 76, 77)

The method of claim 76 or 77 wherein said polypeptide biosensor comprises the peptide conjugate of claim 8 or 42.

### Claim 79 (depends on 76, 77)

The method of claim 76 or 77 wherein said polypeptide biosensor comprises the protein binding domain of p21 protein kinase or the protein binding domain of Wiscott Aldrich syndrome protein.

### Claim 80 (depends on 76, 77)

The method of claim 76 or 77 wherein said Rho GTPase protein domain is derived from a Rac, Rho or cdc42 protein.

### Claim 81 (depends on 76, 77)

The method of claim 76 or 77 which further comprises quantifying the amount of GTP-activated Rho GTPase protein.

### Claim 82 (depends on 8, 42)

A method for detecting binding of an antibody to an antigen which comprises reacting an antibody comprising the peptide conjugate of claim 8 or 42 with an antigen and detecting an antibody-antigen complex.

### Claim 83 (depends on 8, 42)

A method for detecting binding of an antigen to an antibody which comprises reacting an antigen comprising the peptide conjugate of claim 8 or 42 with an antibody and detecting an antibody-antigen complex.

### Claim 84

A fluorescent compound of the formula:
19
wherein:
each m is separately an integer ranging from 1-3;
n is an integer ranging from 0 to 5;
R8, R11 and R12 are separately CO, SO2, C═C(CN)2, S, O or C(CH3)2;
each R13 is alkyl, branched alkyl or heterocyclic ring derivatized with charged groups to enhance water solubility and enhance photostability;
each R9 and R10 is separately an alkyl chain derivatized with charged groups to enhance water solubility or with reactive groups for conjugation to other molecules.

### Claim 85 (depends on 84)

The compound of claim 84 wherein each R9 and R10 is separately sulfonate, amide or ether.

### Claim 86 (depends on 84)

The compound of claim 84 wherein each R9 and R10 is separately —NH—(C═O)—CH2—halide, amine, maleimide, —N═C═O, —N═C═S, acyl halide, succinimidyl ester, sulfosuccinimidyl ester, sulfonyl halide, sulfonyl azide, alcohol, thiol, semicarbazide, hydrazine or hydroxylamine.

### Claim 87 (depends on 84)

The compound of claim 84 wherein each R9 and R10 is separately carboxylic acid, alkali or alkaline earth metal salt of carboxylic acid, carboxylic acid activated by carbodiimide, acyl chloride, succinimidyl, sulfosuccinimidyl ester or COOR-x, wherein x is phenol or naphtol further substituted by at least one strong electron withdrawing group.

### Claim 88 (depends on 84)

The compound of claim 84 having the formula:
20

### Claim 89 (depends on 84)

The compound of claim 84 having the formula:
21

### Claim 90 (depends on 84)

The compound of claim 84 having the formula:
22

### Claim 91 (depends on 84)

A peptide biosensor comprising the compound of claim 84.

### Claim 92 (depends on 84)

A protein, polypeptide, peptide, antibody, antibody fragment or nucleic acid linked to the compound of claim 84.
